Brian M. Gallagher
Directeur/Membre du Conseil chez NB Therapeutics
Profil
Brian M.
Gallagher is currently a Director at NB Therapeutics.
He previously worked as Chairman, President & Chief Executive Officer at CollaGenex Pharmaceuticals, Inc. from 1994 to 2003.
He also served as President & Chief Executive Officer at PPD Dermatology LLC and as a Director at IMCOR Pharmaceutical Co. from 2004 to 2010.
Additionally, he held positions as a Director at Transport Pharmaceuticals, Inc., Solstice Neurosciences, Inc., Bristol Myers Squibb Co., E.I.
du Pont de Nemours & Co., and as Vice President & General Manager at Squibb Diagnostics.
Gallagher holds a doctorate degree from St. John's University.
Postes actifs de Brian M. Gallagher
| Sociétés | Poste | Début |
|---|---|---|
NB Therapeutics
 NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Directeur/Membre du Conseil | 08/10/2010 |
Anciens postes connus de Brian M. Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Président | 01/12/2003 |
Squibb Diagnostics
 Squibb Diagnostics Medical SpecialtiesHealth Technology Part of Bracco SpA, Squibb Diagnostics is an American company that specializes in imaging diagnostics products. Squibb Diagnostics was acquired by Bracco SpA from Bristol Myers Squibb Co. on October 19, 1994. | Corporate Officer/Principal | - |
| E.I. du Pont de Nemours & Co. /Clysar Shrink Film Operations/ | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Directeur/Membre du Conseil | - |
Formation de Brian M. Gallagher
| St. John's University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 8 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Health Technology |
Transport Pharmaceuticals, Inc.
Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
PPD Dermatology LLC
 PPD Dermatology LLC Pharmaceuticals: MajorHealth Technology PPD Dermatology LLC develops novel pharmaceutical products and proprietary medical therapies for the dermatology market. The company provides therapies for skin diseases. It was founded in 2006 and is headquartered in Waltham, MA. | Health Technology |
Solstice Neurosciences, Inc.
 Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Solstice Neurosciences, Inc. was a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
| E.I. du Pont de Nemours & Co. /Clysar Shrink Film Operations/ | Process Industries |
Squibb Diagnostics
Squibb Diagnostics Medical SpecialtiesHealth Technology Part of Bracco SpA, Squibb Diagnostics is an American company that specializes in imaging diagnostics products. Squibb Diagnostics was acquired by Bracco SpA from Bristol Myers Squibb Co. on October 19, 1994. | Health Technology |
NB Therapeutics
NB Therapeutics Pharmaceuticals: MajorHealth Technology NB Therapeutics, Inc. develops pharmacologic therapies. The firm has two technology platforms: iontophoresis and nitric oxide gas, through these two technology platforms it seeks to address the inherent challenges of drug delivery for diseases of the skin and nails. The company was founded by Frank J. McCaney in 2006 and is headquartered in Bristol, PA. | Health Technology |
